Bio-Rad Labs (BIO) Tops Q3 EPS by 5c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $386.11 -0.46%
EPS Growth %: +5.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.3%
Financial Fact:
Foreign exchange losses, net: 1.24M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.59, $0.05 better than the analyst estimate of $0.54. Revenue for the quarter came in at $470 million versus the consensus estimate of $495.55 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
